← All organizations

Biocodex

For profitContributed to NME

Also known as: Biocodex | BIOCODEX SA | Laboratoires Biocodex | Laboratoires Biocodex (Montrouge, France)

Highest phase reached

Phase 4

First clinical trial

Nov 2, 1999

First marketed drug

Aug 20, 2018

First NDA

Aug 20, 2018

Last known activity

Oct 22, 2025

Timeline

1950s

  1. Jul 1, 1953

    Biocodex— Founded

2010s

  1. Aug 20, 2018

    stiripentol— NDA Organization

  2. Aug 20, 2018

    stiripentol— NDA Secondary Org

Drugs by trial phase (9 distinct, 17 trials)

Phase 3 (2 own, 0 via acquisition)

Other trials (3 own, 0 via acquisition)

Indications

Marketed drugs (1)

Recent trials (19)

Details

Founded
Gentilly, FR Jul 1, 1953
First NDA
Aug 20, 2018
Last known activity
Oct 22, 2025

Designations held

  • Orphan drug
  • Priority review